{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:33:26Z","timestamp":1768700006708,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,10,26]],"date-time":"2014-10-26T00:00:00Z","timestamp":1414281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s10792-013-9876-6","type":"journal-article","created":{"date-parts":[[2014,10,25]],"date-time":"2014-10-25T10:58:17Z","timestamp":1414234697000},"page":"1175-1181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The expression of vascular endothelial growth factor in pterygium tissue of atopic patients"],"prefix":"10.1007","volume":"34","author":[{"given":"Hamid","family":"Gharaee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Shayegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Khakzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Kianoush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A-Reza","family":"Varasteh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Sankian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Meshkat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,26]]},"reference":[{"issue":"3","key":"9876_CR1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0002-9394(99)00161-0","volume":"128","author":"TJ Threlfall","year":"1999","unstructured":"Threlfall TJ, English DR (1999) Sun exposure and pterygium of the eye: a dose-response curve. Am J Ophthalmol 128(3):280\u2013287","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"9876_CR2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.optm.2006.05.010","volume":"77","author":"Y Pang","year":"2006","unstructured":"Pang Y, Rose T (2006) Rapid growth of pterygium after photorefractive keratectomy. Optometry 77(10):499\u2013502","journal-title":"Optometry"},{"issue":"3","key":"9876_CR3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0149-2918(03)80115-7","volume":"25","author":"MB Abelson","year":"2003","unstructured":"Abelson MB, Turner D (2003) A randomized, double-blind, parallel-group comparison of olopatadine 0.1\u00a0% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis. Clin Ther 25(3):931\u2013947","journal-title":"Clin Ther"},{"issue":"2","key":"9876_CR4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0002-9394(87)90358-8","volume":"98","author":"OD Pinkerton","year":"1984","unstructured":"Pinkerton OD, Hokama Y, Shigemura LA (1984) Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol 98(2):225\u2013228","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"9876_CR5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00003226-200005000-00021","volume":"19","author":"M Isaji","year":"2000","unstructured":"Isaji M, Kikuchi S, Miyata H, Ajisawa Y, Araki-Inazawa K, Tsukamoto Y, Amano Y (2000) Inhibitory effects of tranilast on the proliferation and functions of human pterygium-derived fibroblasts. Cornea 19(3):364\u2013368","journal-title":"Cornea"},{"issue":"6","key":"9876_CR6","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1167\/iovs.05-1130","volume":"47","author":"N Girolamo Di","year":"2006","unstructured":"Di Girolamo N, Wakefield D, Coroneo MT (2006) UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci 47(6):2430\u20132437","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"9876_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.0022-202X.2003.22101.x","volume":"122","author":"K Yano","year":"2004","unstructured":"Yano K, Kajiya K, Ishiwata M, Hong YK, Miyakawa T, Detmar M (2004) Ultraviolet B-induced skin angiogenesis is associated with a switch in the balance of vascular endothelial growth factor and thrombospondin-1 expression. J Invest Dermatol 122(1):201\u2013208","journal-title":"J Invest Dermatol"},{"issue":"3","key":"9876_CR8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2133.2000.03707.x","volume":"143","author":"S Trompezinski","year":"2000","unstructured":"Trompezinski S, Pernet I, Mayoux C, Schmitt D, Viac J (2000) Transforming growth factor-beta1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human dermal fibroblasts. Br J Dermatol 143(3):539\u2013545","journal-title":"Br J Dermatol"},{"issue":"4","key":"9876_CR9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1398-9995.2007.01593.x","volume":"63","author":"HK Park","year":"2008","unstructured":"Park HK, Park HW, Jeon SG, Shin ES, Gho YS, Cho SH, Kim YY, Kim YK (2008) Distinct association of genetic variations of vascular endothelial growth factor, transforming growth factor-beta, and fibroblast growth factor receptors with atopy and airway hyperresponsiveness. Allergy 63(4):447\u2013453","journal-title":"Allergy"},{"issue":"2","key":"9876_CR10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/187152807780832256","volume":"6","author":"H Kanazawa","year":"2007","unstructured":"Kanazawa H (2007) Microvascular theory of exercise-induced bronchoconstriction in asthma: potential implication of vascular endothelial growth factor. Inflamm Allergy Drug Targets 6(2):133\u2013137","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"11","key":"9876_CR11","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1365-2222.2005.02360.x","volume":"35","author":"A Chetta","year":"2005","unstructured":"Chetta A, Zanini A, Foresi A, D\u2019Ippolito R, Tipa A, Castagnaro A, Baraldo S, Neri M, Saetta M, Olivieri D (2005) Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. Clin Exp Allergy 35(11):1437\u20131442","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"9876_CR12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm1105","volume":"10","author":"CG Lee","year":"2004","unstructured":"Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, Kang MJ, Cohn L, Kim YK, McDonald DM, Elias JA (2004) Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10(10):1095\u20131103","journal-title":"Nat Med"},{"issue":"1","key":"9876_CR13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-3083.2011.02541.x","volume":"74","author":"D Sauma","year":"2011","unstructured":"Sauma D, Espejo P, Ramirez A, Fierro A, Rosemblatt M, Bono MR (2011) Differential regulation of Notch ligands in dendritic cells upon interaction with T helper cells. Scand J Immunol 74(1):62\u201370","journal-title":"Scand J Immunol"},{"issue":"3","key":"9876_CR14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2567.1999.00801.x","volume":"97","author":"J Garssen","year":"1999","unstructured":"Garssen J, Vandebriel RJ, De Gruijl FR, Wolvers DA, Van Dijk M, Fluitman A, Van Loveren H (1999) UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology 97(3):506\u2013514","journal-title":"Immunology"},{"issue":"5","key":"9876_CR15","doi-asserted-by":"crossref","first-page":"L1147","DOI":"10.1152\/ajplung.00294.2006","volume":"292","author":"H Huang","year":"2007","unstructured":"Huang H, Lavoie-Lamoureux A, Moran K, Lavoie JP (2007) IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 292(5):L1147\u2013L1154","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"9876_CR16","first-page":"35","volume":"6","author":"ET Detorakis","year":"2000","unstructured":"Detorakis ET, Drakonaki EE, Spandidos DA (2000) Molecular genetic alterations and viral presence in ophthalmic pterygium. Int J Mol Med 6(1):35\u201341","journal-title":"Int J Mol Med"},{"issue":"1","key":"9876_CR17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1167\/iovs.10-5735","volume":"52","author":"JJ Siak","year":"2011","unstructured":"Siak JJ, Ng SL, Seet LF, Beuerman RW, Tong L (2011) The nuclear-factor kappaB pathway is activated in pterygium. Invest Ophthalmol Vis Sci 52(1):230\u2013236","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"9876_CR18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00003226-200201000-00009","volume":"21","author":"CM Chan","year":"2002","unstructured":"Chan CM, Liu YP, Tan DT (2002) Ocular surface changes in pterygium. Cornea 21(1):38\u201342","journal-title":"Cornea"},{"issue":"4","key":"9876_CR19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1582-4934.2005.tb00379.x","volume":"9","author":"AM Byrne","year":"2005","unstructured":"Byrne AM, Bouchier-Hayes DJ, Harmey JH (2005) Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 9(4):777\u2013794","journal-title":"J Cell Mol Med"},{"issue":"2","key":"9876_CR20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/mp.51.2.55","volume":"51","author":"JA Royds","year":"1998","unstructured":"Royds JA, Dower SK, Qwarnstrom EE, Lewis CE (1998) Response of tumour cells to hypoxia: role of p53 and NFkB. Mol Pathol 51(2):55\u201361","journal-title":"Mol Pathol"},{"issue":"2","key":"9876_CR21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/mvre.1999.2171","volume":"58","author":"CL Grosskreutz","year":"1999","unstructured":"Grosskreutz CL, Anand-Apte B, Duplaa C, Quinn TP, Terman BI, Zetter B, D\u2019Amore PA (1999) Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res 58(2):128\u2013136","journal-title":"Microvasc Res"},{"issue":"3","key":"9876_CR22","first-page":"129","volume":"12","author":"DJ Price","year":"2001","unstructured":"Price DJ, Miralem T, Jiang S, Steinberg R, Avraham H (2001) Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ 12(3):129\u2013135","journal-title":"Cell Growth Differ"},{"issue":"2","key":"9876_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00417-002-0589-1","volume":"241","author":"G Setten van","year":"2003","unstructured":"van Setten G, Aspiotis M, Blalock TD, Grotendorst G, Schultz G (2003) Connective tissue growth factor in pterygium: simultaneous presence with vascular endothelial growth factor\u2014possible contributing factor to conjunctival scarring. Graefes Arch Clin Exp Ophthalmol 241(2):135\u2013139","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"52","key":"9876_CR24","doi-asserted-by":"crossref","first-page":"40725","DOI":"10.1074\/jbc.M006509200","volume":"275","author":"K Suzuma","year":"2000","unstructured":"Suzuma K, Naruse K, Suzuma I, Takahara N, Ueki K, Aiello LP, King GL (2000) Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-Akt-dependent pathways in retinal vascular cells. J Biol Chem 275(52):40725\u201340731","journal-title":"J Biol Chem"},{"issue":"4","key":"9876_CR25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","volume":"56","author":"A Hoeben","year":"2004","unstructured":"Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56(4):549\u2013580","journal-title":"Pharmacol Rev"},{"issue":"1\u20133","key":"9876_CR26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000236988","volume":"107","author":"HF Dvorak","year":"1995","unstructured":"Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR (1995) Vascular permeability factor\/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107(1\u20133):233\u2013235","journal-title":"Int Arch Allergy Immunol"},{"issue":"13","key":"9876_CR27","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/sj.onc.1202527","volume":"18","author":"T Takahashi","year":"1999","unstructured":"Takahashi T, Ueno H, Shibuya M (1999) VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18(13):2221\u20132230","journal-title":"Oncogene"},{"issue":"11","key":"9876_CR28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/ICO.0b013e3181d5d96d","volume":"29","author":"V Sarnicola","year":"2010","unstructured":"Sarnicola V, Vannozzi L, Motolese PA (2010) Recurrence rate using fibrin glue-assisted ipsilateral conjunctival autograft in pterygium surgery: 2-year follow-up. Cornea 29(11):1211\u20131214","journal-title":"Cornea"},{"issue":"4","key":"9876_CR29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3892\/ijmm_00000149","volume":"23","author":"ET Detorakis","year":"2009","unstructured":"Detorakis ET, Spandidos DA (2009) Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (Review). Int J Mol Med 23(4):439\u2013447","journal-title":"Int J Mol Med"},{"issue":"3","key":"9876_CR30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000252980","volume":"43","author":"MR Razeghinejad","year":"2010","unstructured":"Razeghinejad MR, Hosseini H, Ahmadi F, Rahat F, Eghbal H (2010) Preliminary results of subconjunctival bevacizumab in primary pterygium excision. Ophthalmic Res 43(3):134\u2013138","journal-title":"Ophthalmic Res"},{"issue":"11","key":"9876_CR31","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/ICO.0b013e31820ca63f","volume":"30","author":"A Shenasi","year":"2011","unstructured":"Shenasi A, Mousavi F, Shoa-Ahari S, Rahimi-Ardabili B, Fouladi RF (2011) Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial. Cornea 30(11):1219\u20131222","journal-title":"Cornea"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-013-9876-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-013-9876-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-013-9876-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:30:31Z","timestamp":1559262631000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-013-9876-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,26]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["9876"],"URL":"https:\/\/doi.org\/10.1007\/s10792-013-9876-6","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,26]]}}}